A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma

TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis

NCT01556282 ·Status: COMPLETED ·Phase: NA

Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery

NCT02072356 ·Status: COMPLETED ·Phase: EARLY_PHASE1

TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)

NCT00683631 ·Status: COMPLETED

TheraSphere for the Treatment of Liver Metastases

NCT00511862 ·Status: COMPLETED ·Phase: PHASE2

Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

NCT00530010 ·Status: COMPLETED

Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma

NCT01290523 ·Status: TERMINATED ·Phase: NA

TheraSphere® For Treatment of Metastases in Liver

NCT04517643 ·Status: COMPLETED ·Phase: NA

A Non-Randomized Study of Internal Radiation Therapy to the Liver in Patients With Primary Liver Cancer for Whom Surgery is Not Possible.

NCT00152087 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer

NCT01556490 ·Status: COMPLETED ·Phase: NA

A TheraSphere® Advanced Dosimetry Retrospective Global Study in HCC

NCT03295006 ·Status: COMPLETED

Radiolabeled Glass Beads (TheraSphere®) in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery

NCT00039078 ·Status: WITHDRAWN ·Phase: PHASE2

Yttrium Y 90 Glass Microspheres in Treating Patients With Unresectable Hepatocellular Carcinoma

NCT01176604 ·Status: COMPLETED ·Phase: NA

Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

NCT00589030 ·Status: NO_LONGER_AVAILABLE

Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors

NCT00493883 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein

NCT01887717 ·Status: TERMINATED ·Phase: PHASE3

SIR-Spheres® Microspheres Versus Transarterial Chemoembolisation in Patients With Unresectable Hepatocellular Carcinoma

NCT00867750 ·Status: COMPLETED ·Phase: PHASE2

Building Evidence for Ablative Internal Radiation Therapy in Localized HCC Beyond the Up-To-7 Criteria

NCT06773845 ·Status: RECRUITING ·Phase: PHASE2

Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma

NCT01253148 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate Efficacy and Safety of TheraSphere and Resection Combination Therapy in Patients With Single Large ((> 5cm, Long Diameter ) Hepatocellular Carcinoma : Exploratory Trial

NCT05038397 ·Status: COMPLETED ·Phase: NA

Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)

NCT04069468 ·Status: COMPLETED

Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma

NCT07110233 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Hepatocellular Carcinoma Beyond UCSF Criteria Before Liver Transplantation

NCT07310836 ·Status: NOT_YET_RECRUITING

Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors

NCT01177007 ·Status: COMPLETED ·Phase: PHASE2

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

NCT01850667 ·Status: COMPLETED ·Phase: PHASE2

Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk

NCT05620771 ·Status: SUSPENDED ·Phase: PHASE2